PCORI Allocates $156 Million for Groundbreaking Patient-Centered Health Research Initiatives
On December 3, 2024, the Patient-Centered Outcomes Research Institute (PCORI) made a groundbreaking announcement regarding its commitment to enhancing healthcare outcomes. With an impressive allocation of more than $156 million, PCORI is set to fund a series of new patient-centered comparative clinical effectiveness research (CER) studies. The initiative primarily aims to address critical evidence gaps that have persisted in various healthcare domains, including sleep health, maternal health, and services for individuals with intellectual and developmental disabilities.
Among the most pressing issues, poor sleep continues to be a significant concern in the United States, affecting over 50 million individuals. It is often associated with a range of chronic conditions and negative health implications. As stated by PCORI Executive Director, Dr. Nakela L. Cook, this funding will be pivotal in filling crucial evidence gaps regarding sleep interventions, thus empowering patients and caregivers to make informed health decisions about sleep quality, a vital aspect of overall health.
This funding encompasses 13 CER studies, focusing on diverse areas, such as:
In addition to these targeted studies, the funding will also bolster implementation efforts and methodological research within the field. Notable projects include initiatives designed to assist older adults with advanced kidney disease in understanding their treatment options and integrating complementary therapies, such as acupuncture and massage, into cancer care regimens.
PCORI's commitment to enhancing research methods is reflected in its substantial funding of $8 million dedicated to advancing CER methodologies, alongside $7 million earmarked for studies that effectively engage patients and healthcare decision-makers. This approach is critical to ensuring that the research conducted remains relevant and beneficial to those it aims to serve.
PCORI’s funding also supports PCORnet®, a beneficial network that enhances clinical research infrastructure and links research studies with clinical practice throughout the United States. With an infusion of $134 million, this initiative will strengthen eight PCORnet® Clinical Research Networks, further propelling the mission of patient-centered research.
As highlighted by Dr. Harv Feldman, Deputy Executive Director for Patient-Centered Research Programs at PCORI, investing in both methodological advancements and patient engagement research solidifies the integrity of comparative effectiveness studies. This structured, evidence-driven approach is essential for generating credible outcomes that patients and caregivers can trust.
Since its inception in 2010, PCORI has played a vital role in promoting patient-centered research, having allocated more than $4.5 billion to date. The overarching goal remains clear: to generate evidence that supports informed healthcare decisions and improves the overall delivery and quality of healthcare. As an independent, non-profit entity, PCORI continues to be a frontrunner in fostering an inclusive research environment that prioritizes patient involvement at all stages, assuring that their insights are deeply integrated into research activities.
For more detailed information on specific funding awards, the studies involved, and further initiatives, interested parties are encouraged to visit PCORI's official website. These new investments in health research highlight a commitment to tackling existing gaps in evidence and improving healthcare outcomes across the board.
Among the most pressing issues, poor sleep continues to be a significant concern in the United States, affecting over 50 million individuals. It is often associated with a range of chronic conditions and negative health implications. As stated by PCORI Executive Director, Dr. Nakela L. Cook, this funding will be pivotal in filling crucial evidence gaps regarding sleep interventions, thus empowering patients and caregivers to make informed health decisions about sleep quality, a vital aspect of overall health.
This funding encompasses 13 CER studies, focusing on diverse areas, such as:
- - Sleep Interventions: Three of the funded studies will specifically investigate interventions aimed at improving sleep quality. These studies look to explore various methodologies that could lead to better sleep health outcomes for patients.
- - Care for People with Intellectual and Developmental Disabilities: This includes significant research into sleep apnea treatment tailored for individuals with Down syndrome, and early intervention strategies for toddlers exhibiting developmental disabilities. Furthermore, travel training initiatives for young adults with intellectual and developmental disabilities are also part of this funding package.
- - Maternal Health Studies: Two new studies will compare techniques to manage gestational diabetes and postpartum blood pressure, addressing significant health challenges affecting new mothers and their infants.
- - Surgical and Chronic Disease Interventions: The study portfolio also covers areas such as hip fracture recovery, stroke management, inflammatory bowel disease treatment, smoking cessation methodologies, intubation practices in adults, and follow-up care for children with bronchiolitis.
In addition to these targeted studies, the funding will also bolster implementation efforts and methodological research within the field. Notable projects include initiatives designed to assist older adults with advanced kidney disease in understanding their treatment options and integrating complementary therapies, such as acupuncture and massage, into cancer care regimens.
PCORI's commitment to enhancing research methods is reflected in its substantial funding of $8 million dedicated to advancing CER methodologies, alongside $7 million earmarked for studies that effectively engage patients and healthcare decision-makers. This approach is critical to ensuring that the research conducted remains relevant and beneficial to those it aims to serve.
PCORI’s funding also supports PCORnet®, a beneficial network that enhances clinical research infrastructure and links research studies with clinical practice throughout the United States. With an infusion of $134 million, this initiative will strengthen eight PCORnet® Clinical Research Networks, further propelling the mission of patient-centered research.
As highlighted by Dr. Harv Feldman, Deputy Executive Director for Patient-Centered Research Programs at PCORI, investing in both methodological advancements and patient engagement research solidifies the integrity of comparative effectiveness studies. This structured, evidence-driven approach is essential for generating credible outcomes that patients and caregivers can trust.
Since its inception in 2010, PCORI has played a vital role in promoting patient-centered research, having allocated more than $4.5 billion to date. The overarching goal remains clear: to generate evidence that supports informed healthcare decisions and improves the overall delivery and quality of healthcare. As an independent, non-profit entity, PCORI continues to be a frontrunner in fostering an inclusive research environment that prioritizes patient involvement at all stages, assuring that their insights are deeply integrated into research activities.
For more detailed information on specific funding awards, the studies involved, and further initiatives, interested parties are encouraged to visit PCORI's official website. These new investments in health research highlight a commitment to tackling existing gaps in evidence and improving healthcare outcomes across the board.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.